A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis
NCT06477835
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
259
Enrollment
OTHER
Sponsor class
Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL:
SIM0718 Injection
Sponsor
Simcere Pharmaceutical Co., Ltd